Patents/Assignees

Nantkwest, Inc.

2 patents in portfolio

US12427152utility2025
HDAC Inhibitors for Use with NK Cell Based Therapies
0 cites
US12303477utility2025
HIV Treatment Compositions and Methods
0 cites